Hip Surgery in Quiescent or Active Tubercular Hip Arthritis; Is Reactivation Risk Really a Matter.

Ali Parsa, Maryam Mirzaie, Mohammad H Ebrahimzadeh, Ali Birjandinejad, Abdolreza Malek, Alireza Mousavian

Open access · greenAbstract readReview

In one paragraph

Review in The archives of bone and joint surgery, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

0.2field-weighted citation impact, top 42% of its field

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

Short-term outcomes of one-stage debridement and fusion for ankle joint tuberculosis.European journal of orthopaedic surgery & traumatology : orthopedie traumatologie · 2023
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Ali ParsaMassachusetts General Hospital, Harvard Medical School, Boston, MA, USA; Orthopedic Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.

Maryam MirzaieMassachusetts General Hospital, Harvard Medical School, Boston, MA, USA; Orthopedic Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.

Mohammad H EbrahimzadehMassachusetts General Hospital, Harvard Medical School, Boston, MA, USA; Orthopedic Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.

Ali BirjandinejadMassachusetts General Hospital, Harvard Medical School, Boston, MA, USA; Orthopedic Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.

Abdolreza MalekMassachusetts General Hospital, Harvard Medical School, Boston, MA, USA; Orthopedic Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.

Alireza MousavianMassachusetts General Hospital, Harvard Medical School, Boston, MA, USA; Orthopedic Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.

Mashhad University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

About 15 % of all musculoskeletal tuberculosis (TB) have hip involvement. Early anti-tubercular drug therapy and other conservative treatment including short-term traction and mobilization programs could prevent hip joint destruction. Reactivation of TB accounts for a significant of active TB incidence, especially in the developed countries with a low TB prevalence. The risk of TB activation for population with the latent form of disease is about 5-10%. According to the existing literature surgery in tubercular hip arthritis would be safe once sufficient debridement and precise anti tubercular chemotherapy has been done.

Indexed as

activehipquiescentreactivationsurgeryTuberculosis

Identifiers

PMID29911133

PMCPMC5990708

OpenAlexW2802818260

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.